Neuren Pharmaceuticals | NEU - Operating Profit

Stock Price
11.48
Daily Change
0.08 0.70%
Monthly
-12.23%
Yearly
-6.36%
Q1 Forecast
11.51

Neuren Pharmaceuticals reported AUD17.01M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -10.41M 742K Dec/2025
Clinuvel Pharmaceuticals AUD 39.05M 21.49M Jun/2024
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genetic Signatures AUD -6.34M 8.82M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Paradigm Biopharmaceuticals AUD -8.5M 2.57M Jun/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025
Viatris USD -157.5M 392M Dec/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025